Federal Research & Development in Biotechnology (except Nanobiotechnology) contracting in South Carolina.
Federal agencies obligated $1.8B on Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714) performed in South Carolina in FY2024 — the #2 largest federal contracting category in the state, roughly 47.3% of all U.S. federal spend in this NAICS.
How a South Carolina firm wins Research & Development in Biotechnology (except Nanobiotechnology) work
Register on SAM.gov
A SAM.gov registration under NAICS 541714 is required to pursue federal awards. P4 One LLC: SAM.gov registration · UEI SW9VDGLV8AY6.
Target the buyers
See which federal agencies buy this work and respond to their solicitations on SAM.gov.
Respond sharp
A clear capability statement and relevant experience help buyers evaluate a response.
Source: USAspending.gov — federal prime-contract awarding-agency obligations, FY2024 (public record). Figures are historical award totals shown for buyer research, not a forecast, guarantee, or solicitation. Verify current opportunities and eligibility at SAM.gov and the issuing agency.